Retatrutide: A Comprehensive Guide to Uses, Research, Dosing, Forms, and Potential Benefits
Few experimental metabolic peptides have generated as much attention as retatrutide. Developed by Eli Lilly and Company under the research designation LY3437943, retatrutide is being investigated primarily for obesity and related metabolic conditions. The excitement surrounding retatrutide comes from its unusual mechanism of action. While semaglutide targets the GLP-1 receptor and tirzepatide targets both the […]
Continue Reading